Showing 2741-2750 of 3039 results for "".
- Regeneron CEO: Manufacturing Not Up to Snuff for COVID-19 Vaccines, Therapieshttps://modernod.com/news/regeneron-ceo-manufacturing-not-up-to-snuff-for-covid-19-vaccines-therapies/2477753/Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials and an antibody cocktail in development. But success in the clinic means nothing if drugmakers can’t produce a therapy or vaccine fast enough—and the company’s helmsman i
- Optogenetic Gene Therapy Well Tolerated For Retinitis Pigmentosahttps://modernod.com/news/optogenetic-gene-therapy-well-tolerated-for-retinitis-pigmentosa/2477737/New findings presented on ARVOLearn showed that an optogenetic gene therapy was well tolerated in a group of patients with end-stage non-syndromic retinitis pigmentosa, according to a
- Bausch + Lomb Licenses Exclusive Rights To a Biosimilar Candidate for Lucentis (Ranibizumab) in the US and Canadahttps://modernod.com/news/bausch-lomb-licenses-exclusive-rights-to-a-biosimilar-candidate-for-lucentis-ranibizumab-in-the-us-and-canada/2477718/Bausch + Lomb has entered into an exclusive licensing agreement with STADA Arzneimittel AG and its development partner, Xbrane Biopharma AB, a Nordic biosimilar developer, to develop and commercialize a biosimilar candidate to Lucentis (ranibizumab) in the United States and Canada. The companies
- AbbVie, Allergan Gain US Antitrust Clearance for Dealhttps://modernod.com/news/abbvie-allergan-gain-us-antitrust-clearance-for-deal/2477714/The US Federal Trade Commission (FTC) accepted the proposed consent order in connection with AbbVie’s pending $63-billion acquisition of Allergan, the companies announced. The FTC’s decision means that all required antitrust clearances needed for the merger have now been obtained.
- Massachusetts Eye and Ear Advancing Experimental Gene-Based COVID-19 Vaccine, AAVCOVIDhttps://modernod.com/news/massachusetts-eye-and-ear-advancing-experimental-gene-based-covid-19-vaccine-aavcovid/2477708/Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham, announced progress toward the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The
- Icare USA New Confocal Fundus Imaging System and Handheld Tonometerhttps://modernod.com/news/icare-usa-new-confocal-fundus-imaging-system-and-handheld-tonometer/2477707/Icare USA announced the release of two new diagnostic technologies: the Centervue DRSplus confocal fundus imaging system, and the Icare ic200 handheld tonometer for portable measurement of IOP. “We’re excited to introduce clinicians to these new technologies—the disruptive DRSplus platform
- Studies Yield Mixed Findings for Investigational Drug Abicipar in Wet AMDhttps://modernod.com/news/studies-yield-mixed-findings-for-investigational-drug-abicipar-in-wet-amd/2477703/The investigational drug abicipar pegol is noninferior to ranibizumab for achieving stable vision in people with wet age-related macular degeneration (AMD), according to a pair of phase-3 trials, as reported by Reuters.wet Abicipar
- SightGlass Vision Announces R&D Webinar Featuring Leading Myopia Expertshttps://modernod.com/news/sightglass-vision-announces-rd-webinar-featuring-leading-myopia-experts/2477704/SightGlass Vision announced it will hold an R&D webinar to discuss the science of and latest research in myopia, as well as provide an overview about the clinical development and commercialization program for the company’s novel glasses designed to slow the progression of myopia in chil
- BVI Names David Murray as Chief Financial Officerhttps://modernod.com/news/bvi-names-david-murray-as-chief-financial-officer/2477662/BVI announced that it has named David Murray as Chief Financial Officer. Most recently, Mr. Murray served as Chief Financial Officer of Alcon from 2015 until its $30bn spin-off from Novartis Group AG in 20
- New Dates Announced for BMC Virtual Spring Symposiumhttps://modernod.com/news/new-dates-announced-for-bmc-virtual-spring-symposium/2477658/Bryn Mawr Communications (BMC) has announced that its first virtual educational initiative, the BMC Virtual Spring Symposium, will now be held on May 29-30. The BMC Virtual Spring Symposium is designed to enable discussion, engagement, and live Q&A for members of the vision community w